Status:

COMPLETED

Prospective, Randomized, Multicenter, Control Study to Assess the Efficacy and Safety of Tacrolimus in Induction and Maintenance Phase Treatment in Lupus Nephritis

Lead Sponsor:

Sun Yat-sen University

Conditions:

Kidney Diseases

Lupus Nephritis

Eligibility:

All Genders

14-65 years

Phase:

PHASE3

Brief Summary

The purpose of this study is to compare the efficacy and safety of tacrolimus vs intravenous cyclophosphamide pulses treatment for the induction therapy of LN(III,IV,V). To compare the efficacy and s...

Eligibility Criteria

Inclusion

  • Subjects of either sex, 14-65 years of age;
  • Diagnosis of SLE according to the ACR criteria(1997);
  • Kidney biopsy within the 6 months prior to first randomization with a histologic diagnosis (ISN/RPS 2003 classification of LN) class III, IV, V;
  • Class IV LN: proteinuria \>1g/24hr or Scr\>115umol/L;
  • Class III or V LN: proteinuria \>2g/24hr or Scr\>115umol/L;
  • Provision of written informed consent by subject or guardian.

Exclusion

  • Inability or unwillingness to provide written informed consent ;
  • Known hypersensitivity or contraindication to tacrolimus, cyclophosphamide , azathioprine, corticosteroids;
  • Usage of immunosuppression therapy (MMF, CTX, CysA, MTX ect) for more than 1 week within 1 month prior to first randomization;
  • Pregnancy, nursing or use of a non-reliable method of contraception;
  • Continuous dialysis starting more than 2 weeks before randomization into the induction phase and/or continuous dialysis with an anticipated duration of more than 8 weeks;
  • Previous kidney transplant or planted transplant;
  • Scr \> 4mg/dl (353umol/L);
  • Active hepatitis, with liver dysfunction;
  • Diagnosed DM;
  • Participation in another clinic trial and/or receipt of investigational drugs within 4 weeks prior to screening .

Key Trial Info

Start Date :

July 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 1 2008

Estimated Enrollment :

81 Patients enrolled

Trial Details

Trial ID

NCT00615173

Start Date

July 1 2006

End Date

September 1 2008

Last Update

October 29 2008

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The 1st Affiliated Hospital, Sun Yet-sen University

Guangzhou, Guangdong, China, 510080